Steven Cohen’s First Tracks Biotherapeutics TRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.8M Buy
417,991
+9,661
+2% +$377K 0.02% 1097
2026
Q2
$8.22M Buy
+408,330
New +$7.63M 0.01% 1406

Other funds holding TRAX

Steven Cohen's TRAX Position: Q3 2026 in Review

Steven Cohen increased its First Tracks Biotherapeutics (TRAX) stake by 2.4% in Q3 2026, buying an estimated $377K and bringing the position to 417,991 shares worth $14.8M. The position accounts for 0.02% of the portfolio, ranked #1097.

Steven Cohen first reported a position in TRAX in Q2 2026 and has held it in 2 quarters since. 180 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.

  • Steven Cohen held 417,991 shares of First Tracks Biotherapeutics worth $14.8M as of Q3 2026.
  • Steven Cohen bought 9,661 First Tracks Biotherapeutics shares in Q3 2026, an estimated $377K.
  • First Tracks Biotherapeutics made up 0.02% of Steven Cohen's portfolio in Q3 2026, its #1097 holding.
  • Steven Cohen first reported a position in First Tracks Biotherapeutics in Q2 2026 and has held it in 2 quarters since.
  • 180 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.